These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17564969)

  • 21. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
    Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
    Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene augmentation for adRP mutations in RHO.
    Lewin AS; Rossmiller B; Mao H
    Cold Spring Harb Perspect Med; 2014 Jul; 4(9):a017400. PubMed ID: 25037104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture.
    Palfi A; Ader M; Kiang AS; Millington-Ward S; Clark G; O'Reilly M; McMahon HP; Kenna PF; Humphries P; Farrar GJ
    Hum Mutat; 2006 Mar; 27(3):260-8. PubMed ID: 16419083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach.
    Kiang AS; Palfi A; Ader M; Kenna PF; Millington-Ward S; Clark G; Kennan A; O'reilly M; Tam LC; Aherne A; McNally N; Humphries P; Farrar GJ
    Mol Ther; 2005 Sep; 12(3):555-61. PubMed ID: 15967729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele-specific gene-editing approach for vision loss restoration in
    Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
    Elife; 2023 Jun; 12():. PubMed ID: 37272616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis.
    Marrocco E; Maritato R; Botta S; Esposito M; Surace EM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing gene therapy for mutant membrane, secretory, and lipid proteins in retinitis pigmentosa (RP).
    Shinohara T; Mulhern ML; Madson CJ
    Med Hypotheses; 2008; 70(2):378-80. PubMed ID: 17590524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
    Sudharsan R; Beltran WA
    Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.
    Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS
    Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel p.M96T variant of NRL and shRNA-based suppression and replacement of NRL mutants associated with autosomal dominant retinitis pigmentosa.
    Hernan I; Gamundi MJ; Borràs E; Maseras M; García-Sandoval B; Blanco-Kelly F; Ayuso C; Carballo M
    Clin Genet; 2012 Nov; 82(5):446-52. PubMed ID: 21981118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15.
    Botta S; de Prisco N; Marrocco E; Renda M; Sofia M; Curion F; Bacci ML; Ventrella D; Wilson C; Gesualdo C; Rossi S; Simonelli F; Surace EM
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-based therapies for dominantly inherited retinopathies.
    Farrar GJ; Millington-Ward S; Chadderton N; Humphries P; Kenna PF
    Gene Ther; 2012 Feb; 19(2):137-44. PubMed ID: 22089493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa.
    Tsai YT; Wu WH; Lee TT; Wu WP; Xu CL; Park KS; Cui X; Justus S; Lin CS; Jauregui R; Su PY; Tsang SH
    Ophthalmology; 2018 Sep; 125(9):1421-1430. PubMed ID: 29759820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
    Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
    CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an inbred miniature pig model of retinitis pigmentosa.
    Ross JW; Fernandez de Castro JP; Zhao J; Samuel M; Walters E; Rios C; Bray-Ward P; Jones BW; Marc RE; Wang W; Zhou L; Noel JM; McCall MA; DeMarco PJ; Prather RS; Kaplan HJ
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):501-7. PubMed ID: 22247487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nature of dominant mutations of rhodopsin and implications for gene therapy.
    Wilson JH; Wensel TG
    Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
    Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
    FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment.
    Sung CH; Makino C; Baylor D; Nathans J
    J Neurosci; 1994 Oct; 14(10):5818-33. PubMed ID: 7523628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78.
    Gorbatyuk MS; Knox T; LaVail MM; Gorbatyuk OS; Noorwez SM; Hauswirth WW; Lin JH; Muzyczka N; Lewin AS
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5961-6. PubMed ID: 20231467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
    O'Neill B; Millington-Ward S; O'Reilly M; Tuohy G; Kiang AS; Kenna PF; Humphries P; Farrar GJ
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2863-9. PubMed ID: 10967039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.